Skip to content

Clinical trials

Carcinoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Country / region: Taiwan Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20082
20094
20103
20141
20163
20172
20183
20197
20203
20215
20223
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting11
Recruiting9
Terminated6
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Pfizer5
Merck Sharp & Dohme LLC4
Novartis Pharmaceuticals3
Australasian Gastro-Intestinal Trials Group2
Bayer2
Blueprint Medicines Corporation2
Exelixis2
AVEO Pharmaceuticals, Inc.1
Abbott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma46
Carcinoma, Non-Small-Cell Lung22
Neoplasms15
Lung Neoplasms14
Adenocarcinoma11
Neoplasm Metastasis10
Neoplasms by Site9
Neoplasms by Histologic Type8
Lung Diseases7
Carcinoma, Hepatocellular6

Trials

Showing 51 to 46 of 46. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.